Azelastine

Results: 72



#Item
31STEP THERAPY POLICY Nasal Steroids Preferred Step Therapy Program To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Beconase AQ® (beclomethasone nasal spray – GlaxoSmithKline)

STEP THERAPY POLICY Nasal Steroids Preferred Step Therapy Program To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Beconase AQ® (beclomethasone nasal spray – GlaxoSmithKline)

Add to Reading List

Source URL: statehealthplan.state.nc.us

Language: English - Date: 2014-09-02 09:27:20
32DOCUMENT INFORMATION PAGE

DOCUMENT INFORMATION PAGE

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-09-14 08:01:38
33

PDF Document

Add to Reading List

Source URL: www.aaia.ca

Language: English - Date: 2010-06-22 02:56:55
34These highlights do not include all the information needed to use XYZAL safely and effectively. See full prescribing information for XYZAL. XYZAL (levocetirizine dihydrochloride) 5 mg tablets 2.5 mg/5 mL (0.5 mg/mL) oral

These highlights do not include all the information needed to use XYZAL safely and effectively. See full prescribing information for XYZAL. XYZAL (levocetirizine dihydrochloride) 5 mg tablets 2.5 mg/5 mL (0.5 mg/mL) oral

Add to Reading List

Source URL: www.fda.gov

Language: English
35Abbreviated Process for PAC- No Presentation Full Safety Review Provided in Briefing Packet * Patanase Spray (olopatadine HCl) * Astepro Spray (azelastine HCl) * Bepreve (bepotastine besilate ophthalmic solution) 1.5% *

Abbreviated Process for PAC- No Presentation Full Safety Review Provided in Briefing Packet * Patanase Spray (olopatadine HCl) * Astepro Spray (azelastine HCl) * Bepreve (bepotastine besilate ophthalmic solution) 1.5% *

Add to Reading List

Source URL: www.fda.gov

    36HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ASTEPRO® Nasal Spray safely and effectively. See full prescribing information for ASTEPRO Nasal Spray.

    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ASTEPRO® Nasal Spray safely and effectively. See full prescribing information for ASTEPRO Nasal Spray.

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2009-09-21 16:08:17
    37CLINICAL REVIEW   Application Type Submission Number Submission Code

    CLINICAL REVIEW Application Type Submission Number Submission Code

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    38[removed]Azelastine Clinical1 PREA

    [removed]Azelastine Clinical1 PREA

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    39022288_Bepotastine_Clinical_PREA

    022288_Bepotastine_Clinical_PREA

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    40[removed]Azelastine Statistical1 PREA

    [removed]Azelastine Statistical1 PREA

    Add to Reading List

    Source URL: www.fda.gov

    Language: English